Long-Term Follow-up Protocol
NCT04917887
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Dystrophic Epidermolysis Bullosa
Recessive Dystrophic Epidermolysis Bullosa
Dominant Dystrophic Epidermolysis Bullosa
Sponsor
Krystal Biotech, Inc.